CS226020B2 - Method of preparing pyridine and pyrimidine derivatives - Google Patents

Method of preparing pyridine and pyrimidine derivatives Download PDF

Info

Publication number
CS226020B2
CS226020B2 CS806985A CS698580A CS226020B2 CS 226020 B2 CS226020 B2 CS 226020B2 CS 806985 A CS806985 A CS 806985A CS 698580 A CS698580 A CS 698580A CS 226020 B2 CS226020 B2 CS 226020B2
Authority
CS
Czechoslovakia
Prior art keywords
compound
solution
compounds
reaction
dose
Prior art date
Application number
CS806985A
Other languages
Czech (cs)
English (en)
Inventor
Joseph G Lombardino
Charles A Harbert
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to CS816610A priority Critical patent/CS226034B2/cs
Publication of CS226020B2 publication Critical patent/CS226020B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01D—HARVESTING; MOWING
    • A01D34/00—Mowers; Mowing apparatus of harvesters
    • A01D34/001—Accessories not otherwise provided for
    • A01D34/003—Means for cleaning the machine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C33/00—Moulds or cores; Details thereof or accessories therefor
    • B29C33/56—Coatings, e.g. enameled or galvanised; Releasing, lubricating or separating agents
    • B29C33/60—Releasing, lubricating or separating agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C70/00—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts
    • B29C70/68—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks
    • B29C70/84—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks by moulding material on preformed parts to be joined
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/0604—Construction of the male part
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/068—Special features relating to lubrication

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental Sciences (AREA)
  • Composite Materials (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
CS806985A 1979-10-15 1980-10-15 Method of preparing pyridine and pyrimidine derivatives CS226020B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS816610A CS226034B2 (en) 1979-10-15 1981-09-08 Method of preparing pyridine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/085,011 US4246263A (en) 1979-10-15 1979-10-15 Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CS226020B2 true CS226020B2 (en) 1984-03-19

Family

ID=22188737

Family Applications (2)

Application Number Title Priority Date Filing Date
CS806985A CS226020B2 (en) 1979-10-15 1980-10-15 Method of preparing pyridine and pyrimidine derivatives
CS816610A CS226034B2 (en) 1979-10-15 1981-09-08 Method of preparing pyridine derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS816610A CS226034B2 (en) 1979-10-15 1981-09-08 Method of preparing pyridine derivatives

Country Status (39)

Country Link
US (1) US4246263A (no)
JP (1) JPS5663962A (no)
KR (2) KR840001614B1 (no)
AR (3) AR226864A1 (no)
AT (2) AT377513B (no)
AU (1) AU517763B2 (no)
BE (1) BE885709A (no)
CA (1) CA1156231A (no)
CH (1) CH646425A5 (no)
CS (2) CS226020B2 (no)
DD (2) DD154816B3 (no)
DE (1) DE3038593A1 (no)
DK (1) DK152427C (no)
EG (1) EG14676A (no)
ES (2) ES8201972A1 (no)
FI (1) FI75560C (no)
FR (1) FR2467199A1 (no)
GB (2) GB2092133B (no)
GR (1) GR70311B (no)
HK (2) HK1185A (no)
HU (2) HU183233B (no)
IE (1) IE50665B1 (no)
IL (1) IL61261A (no)
IN (2) IN154554B (no)
IT (1) IT1195269B (no)
KE (2) KE3461A (no)
LU (1) LU82844A1 (no)
MY (2) MY8500325A (no)
NL (1) NL8005652A (no)
NO (1) NO156566C (no)
NZ (1) NZ195246A (no)
PH (1) PH18277A (no)
PL (2) PL125314B1 (no)
PT (1) PT71917B (no)
SE (1) SE437023B (no)
SG (2) SG56384G (no)
SU (2) SU1083907A3 (no)
YU (2) YU41740B (no)
ZA (1) ZA806306B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371696A (en) * 1980-07-14 1983-02-01 Pfizer Inc. Certain pyridine methylthio acetaldehyde derivatives and non-cyclic and cyclic acetals thereof
GB8405896D0 (en) * 1984-03-07 1984-04-11 Sandoz Ltd Organic compounds
EP0311616B1 (en) * 1986-06-17 1991-09-25 Biogen, Inc. Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents for treating diseases
WO2003024955A2 (en) * 2001-09-18 2003-03-27 Sunesis Pharmaceuticals, Inc. Small molecule inhibitors of caspases
US8143453B2 (en) * 2005-02-25 2012-03-27 Temple University—Of the Commonwealth System of Higher Education Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis
JP5287033B2 (ja) * 2007-08-23 2013-09-11 住友化学株式会社 含フッ素有機硫黄化合物およびその有害節足動物防除剤
CN108530606B (zh) * 2018-04-19 2020-11-20 山东师范大学 一种pH敏感性医用聚氨酯脲材料及其制备方法
US11981625B2 (en) 2018-10-08 2024-05-14 Ecolab Usa Inc. Sulfide-based compounds and uses thereof
CN110483740B (zh) * 2019-08-12 2021-08-27 山东师范大学 一种聚合物、pH敏感性纳米囊泡及制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409626A (en) * 1963-09-17 1968-11-05 Neisler Lab Inc Indolylethyl pyridinium quaternary ammonium compounds
NL144484B (nl) * 1967-07-26 1975-01-15 Merck & Co Inc Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren.
US3558640A (en) * 1967-12-20 1971-01-26 Merck & Co Inc Certain pyridyl and thiazolyl methylthiopropionic acids and derivatives
US3636074A (en) * 1968-08-05 1972-01-18 Hooker Chemical Corp Novel mercaptophenol derivatives
US3591584A (en) 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3818009A (en) * 1969-12-29 1974-06-18 Lilly Co Eli Alpha, alpha-disubstituted-5-pyrimidinemethanes
US3676463A (en) 1970-10-15 1972-07-11 Pfizer Oxobenzofuran carboxamides
US3707475A (en) 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives

Also Published As

Publication number Publication date
SU1083907A3 (ru) 1984-03-30
SG69184G (en) 1985-03-15
PL231782A1 (no) 1982-03-01
US4246263A (en) 1981-01-20
KR840001615B1 (ko) 1984-10-11
FI75560C (fi) 1988-07-11
NO156566C (no) 1987-10-14
DD154816A5 (de) 1982-04-21
AR227576A1 (es) 1982-11-15
EG14676A (en) 1985-03-31
BE885709A (fr) 1981-04-14
HU191824B (en) 1987-04-28
YU262680A (en) 1983-09-30
KR840001614B1 (ko) 1984-10-11
AT379801B (de) 1986-03-10
DE3038593C2 (no) 1988-11-10
ZA806306B (en) 1981-10-28
PL125314B1 (en) 1983-04-30
IE50665B1 (en) 1986-06-11
MY8500325A (en) 1985-12-31
JPS6129342B2 (no) 1986-07-05
LU82844A1 (fr) 1981-06-04
FR2467199B1 (no) 1984-12-28
DK152427C (da) 1988-07-25
HU183233B (en) 1984-04-28
FI803239L (fi) 1981-04-16
SE437023B (sv) 1985-02-04
CH646425A5 (fr) 1984-11-30
HK66887A (en) 1987-09-25
IL61261A0 (en) 1980-12-31
PT71917B (en) 1983-01-10
NL8005652A (nl) 1981-04-21
SG56384G (en) 1985-03-08
HK1185A (en) 1985-01-11
YU42059B (en) 1988-04-30
DE3038593A1 (de) 1981-04-23
DK152427B (da) 1988-02-29
ATA268783A (de) 1985-07-15
NO803073L (no) 1981-04-21
FI75560B (fi) 1988-03-31
YU266882A (en) 1983-09-30
ES8206478A1 (es) 1982-08-16
MY8500323A (en) 1985-12-31
AU517763B2 (en) 1981-08-27
DK403080A (da) 1981-04-16
IT1195269B (it) 1988-10-12
PT71917A (en) 1980-12-01
ES495932A0 (es) 1982-01-16
DD202543A5 (de) 1983-09-21
KE3461A (en) 1984-10-12
AR227089A1 (es) 1982-09-15
JPS5663962A (en) 1981-05-30
GB2061928A (en) 1981-05-20
ATA508980A (de) 1984-08-15
CS226034B2 (en) 1984-03-19
PH18277A (en) 1985-05-17
YU41740B (en) 1987-12-31
IL61261A (en) 1984-08-31
FR2467199A1 (fr) 1981-04-17
ES8201972A1 (es) 1982-01-16
SE8007193L (sv) 1981-04-16
GB2092133A (en) 1982-08-11
NZ195246A (en) 1983-07-15
GB2061928B (en) 1983-06-02
IN163553B (no) 1988-10-08
DD154816B3 (de) 1987-05-13
AR226864A1 (es) 1982-08-31
IE802125L (en) 1981-04-15
PL125402B1 (en) 1983-05-31
SU1144617A3 (ru) 1985-03-07
IT8025324A0 (it) 1980-10-14
ES505544A0 (es) 1982-08-16
GR70311B (no) 1982-09-08
GB2092133B (en) 1983-03-16
IN154554B (no) 1984-11-10
NO156566B (no) 1987-07-06
PL227307A1 (no) 1981-11-13
AU6324080A (en) 1981-04-30
KR830004263A (ko) 1983-07-09
CA1156231A (en) 1983-11-01
KE3466A (en) 1984-11-09
AT377513B (de) 1985-03-25

Similar Documents

Publication Publication Date Title
DE69024896T2 (de) Chinonderivate und ihre pharmakologische Verwendung
KR960007524B1 (ko) 치환된 이미다졸릴-알킬-피페라진 및 -디아제핀 유도체
DE69217312T2 (de) Tricyclische Heterocyclen als PGE2-Antagonisten
UA43841C2 (uk) Імідазопіридини та фармацевтична композиція на їх основі
JPS6253504B2 (no)
SK45096A3 (en) Alkoxy alkyl carbamates from imidazo (1,2-a)pyridines, preparation method thereof, pharmaceutical composition containing them and their use
EP0072926A1 (de) 2-Aryl-imidazopyridine
DE3035086C2 (no)
DE3032669A1 (de) Substituierte oxirancarbonsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
CS226020B2 (en) Method of preparing pyridine and pyrimidine derivatives
KR900006724B1 (ko) 벤조티아진 디옥사이드 유도체
DE3320102C2 (no)
US4929616A (en) Novel basic-substituted 5-halo-thienoisothiazol-3(2H)-one 1,1-dioxides, a process for the preparation thereof, and pharmaceutical preparations containing these compounds
US4927821A (en) Enol ethers of 6-chloro-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide, and their use
JPH07252260A (ja) 新規チエノチアジン誘導体、その製造方法及びその使用方法
GB2193210A (en) Glycine derivatives
JPS6231719B2 (no)
US3923996A (en) 3-Substituted-oxindoles in compositions and methods of treating obesity
EP0302303A2 (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
JPH0710863B2 (ja) エーテル化若しくはエステル化しうるジヒドロキシ基により位置２で置換された４―ｏｈキノリンカルボン酸の新規の誘導体、その製造方法、及び医薬としてのその使用
CS228929B2 (cs) Způsob výroby ve vodě rozpustných solí N-(2-pyridyl)-2-methyl-4-hydroxy-2H-l,2-benzothiazin-3-karboxamid-l,l-dioxidu
RU2068415C1 (ru) 5,7-диокси-2-метил-8-/4-(3-окси-1-(1-пропил)пиперидинил/-4н-1-бензопиран-4-он или его стереоизомеры или фармакологически приемлемые кислотно-аддитивные соли и способ их получения
EP0058009A1 (en) Novel benzanilide derivatives and pharmaceutical compositions containing them
EP0081719B1 (de) 2-Nitroimidazole
IE51727B1 (en) Pyridine derivatives as immunoregulatory agents